Professor Winston Morgan

Winston Morgan's research interests are many and varied, he has been a member of the British Toxicology Society, British Pharmacology Society  and Biochemical Society for over 20 years as well as a Fellow of the Institute of Biology. His early research was in signal transduction in blood cells and the protein chemistry of auto-antibodies, he then moved on to liver and kidney toxicity. He is well into double figures for PhD supervision. Past students have been in areas as diverse as human placenta as an alternative to animals in toxicity testing, the role of probiotics and prebiotics in gut health and wound healing properties of certain Nigerian plants.  He has an ongoing interest in the toxicity of Amphetamine related compounds. Professor Morgan also has projects on the understanding the mechanism of the long term toxicity of highly active antiretroviral therapy (HAART) in AIDS patients. His most recently completed PhD students worked on providing a better understanding of how Paracetamol and NSAID works in terms of anti-pyresis and anti-inflammation. His research has been informed by a knowledge of mechanistic toxicology, toxicity testing, pharmacology and clinical biochemistry. His current students are working toxicity associated with e-cigarette and water-pipe smoking, screening medical plants for anti-cancer compounds and post-mortem insulin analysis in hypoglycaemic death.

Away from laboratory-based research Professor Morgan is involved in several learning and teaching projects looking at how to improve the student experience and performance of widening participation students particularly, BAME students. Supporting postgraduate research students from BAME and widening participation backgrounds to complete their programmes. This work has led to several national keynote presentations. 

A developing area of research and scholarly activity is the role of race and ethnicity in medical research and medical outcomes. In particular of the psychological impacts  of racism is translated into physiological and molecular changes in the affected individuals leading to premature ageing, increased disease susceptibility and early death.